logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Healthcare Services
Filter

Healthcare Services

Categories

Sectors

Locations

Exchange

默克92亿美元收购Cidara,押注流感新药

Merck’s $92 Billion Acquisition of Cidara Bets on New Flu Drug

Nov 20, 2025

Life Science

Abbott to Acquire Exact Sciences in a $21 Billion Deal, Boosting Cancer Diagnostics Push

Abbott to Acquire Exact Sciences in a $21 Billion Deal, Boosting Cancer Diagnostics Push

Nov 20, 2025

Life Science

收购传闻推动Exact Sciences股价飙升,市场关注潜在交易进展

Acquisition Rumors Drive Exact Sciences Stock Price Surge, Market Watches Potential Deal Progress

Nov 19, 2025

Life Science

Forget Timing the Market, These 3 Dividend Kings Let You Sleep Through the Noise

Dividend Kings Expand to 56 Members, Healthcare Sector Contributes Four Resilient Players

Nov 18, 2025

Life Science

为何巴菲特持有的联合健康或被低估并且有望超越Palantir?

Why Is UnitedHealth Group Undervalued and Poised to Outperform Palantir?

Nov 18, 2025

Life Science

资金与政策共振,生物科技ETF迎来布局良机

With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity

Nov 17, 2025

Life Science

安进三季度业绩强劲,多领域布局驱动长期价值 

Amgen’s Strong Q3 Performance and Multi-Faceted Strategy Drive Long-Term Value

Nov 11, 2025

Life Science

GLP-1降价风暴:礼来与诺和诺德展开“以价换量”战略博弈

GLP-1 Price Cut Storm: Lilly and Novo Nordisk Engage in Strategic “Volume-for-Value” Game

Nov 10, 2025

Life Science

Stop Chasing Overvalued Tech: These 2 Underrated Growth Stocks Are Too Cheap To Ignore

Hims & Hers Health Soars on Strong Growth and Strategic Shifts

Nov 9, 2025

Life Science

Metsera减重药物临床数据亮眼,引发制药巨头竞购战

Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants

Nov 6, 2025

Life Science

美政府促成减肥药历史性降价,协议定价245美元

U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245

Nov 6, 2025

Life Science

获亿万富翁重仓押注,梯瓦制药业绩与管线双驱动

Teva Pharmaceutical’s Stock Soars on Better-Than-Expected Earnings

Nov 5, 2025

Life Science

礼来公司:GLP-1药物驱动下的高增长与潜在挑战

Eli Lilly: High Growth Driven by GLP-1 Drugs and Potential Challenges

Nov 5, 2025

Life Science

一个月股价翻四倍,Metsera减肥药技术引巨头竞购

Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month

Nov 4, 2025

Life Science

High-Yield Healthcare Plays: MPT and Pfizer Offer 7% and 6.4% Dividends as Markets Turn Choppy

Defensive Plays for a Bear Market: 3 Healthcare Stocks with Robust Dividends

Nov 3, 2025

Life Science

Three Canadian Growth Stocks Garner Unanimous "Strong Buy" Ratings from Analysts

Three Canadian Growth Stocks Garner Unanimous “Strong Buy” Ratings from Analysts

Nov 3, 2025

Life Science

专利悬崖下的辉瑞如何谋未来?

How is Pfizer Planning for the Future Under the Patent Cliff?

Nov 3, 2025

Life Science

逆市大涨!生物技术公司格劳科斯股价飙升近14%

Defying Market Trend, Biotechnology Company Glaukos Soars Nearly 14%

Oct 31, 2025

Life Science

  • ‹‹ Previous
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada